Lumayno, Airene C.
HRN: 23-65-38 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/05/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
09/05/2023
09/11/2023
IVT
1.5g
Q6
Soft Tissue Injury Sec To MVA; T/c MBTI Sec To MVA
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes